We’re excited to announce that Berkeley Lights and IsoPlexis are moving forward together as PhenomeX, a premier functional cell biology company. Visit Site

Selective Cell Cloning for better clones and accelerated campaign timelines
Custom Productivity Assay for selection of cell lines expressing a wide range of therapeutic proteins and vaccines

Please fill out the following form to access this resource:

First Name*
Last Name*
Email Address*
Phone Number*
City*
Country*
State*
Company/Institute*
CAPTCHA

Related Resources

View All Resources

Cell Line Development

Fireside Chat: Every Day Matters – Optimizing COVID-19 Therapies for Manufacturing

Dr. James Rothman, Nobel Laureate hosts an in-depth discussion with distinguished guests, Dr. Jennitte Stevens from Amgen, Dr. Gregory Bleck from Catalent-Biologics, and Dr. Trent Munro from the University of Queensland on fast-tracking the development of therapeutic antibodies and vaccines for SARS-CoV-2.

Cell Line Development

App Note: FDA-Accepted Monoclonality Assurance on the Beacon® Optofluidic System for Cell Line Development

Learn how the Beacon system’s superior cloning technology, automated imaging capabilities, and in-process quality controls provide definitive evidence of monoclonality to support regulatory approvals.

Cell Line Development

INFO SHEET: Detection Reagents for the Custom Productivity Assay

Detection reagents for the Custom Productivity and Bispecific Heterodimer Assays are fluorescent molecules that bind to the secreted protein of interest and are used to quantify the amount of this protein produced by the cells being assayed.